Olive Diagnostics

Passive Sensor for Urinalysis

Health Tech & Life Sciences
Active
Seed Jerusalem, Israel Founded 2019
Last updated 2026-06-18
Total raised
$11.8M
Last: 2023-05
Stage
Seed
Founded
2019
Headcount
18
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Olive Diagnostics has developed a noninvasive passive urinalysis sensor that provides real-time health alerts, early detection, and information on disease progression.

Using optics for data collection, the sensor is mounted inside the toilet and does not require further intervention. The sensor detects the composition of the urine and sends the data to the cloud. AI algorithms then process the sample to detect the molecular composition and characteristics of the urine. The findings are sent back to either the user via a mobile application or the user’s medical supervisor, and the biomarker data is also sent directly to the electronic health record system for physician and provider accessibility.

The device monitors the duration and biomarkers for hydration; pregnancy; ovulation; red blood cells (for early detection of kidney stones); white blood cells (for detection of urinary tract infections); protein (related to preeclampsia, infections, prediabetes, and diabetes); electrolytes; changes in urination patterns, including volume, time of day, frequency, and duration; glucose; ketones; and specific gravity (for hepatorenal syndrome).

Funding history · 7 rounds · $11.8M total

2023-03
Undisclosed
2023-01
Grant $1.0M
2022-01
Grant $1.0M
2022-01

Q&A

What is Olive Diagnostics' primary offering?
Olive Diagnostics has developed a noninvasive passive urinalysis sensor that provides real-time health alerts, early detection, and information on disease progression by detecting the composition of urine.
When was Olive Diagnostics founded?
Olive Diagnostics was founded in January 2019.
What is the total amount of funding Olive Diagnostics has raised to date?
Olive Diagnostics has raised a total of $11,750,000 USD.
Which investors participated in Olive Diagnostics' funding round in September 2022?
In September 2022, Olive Diagnostics received funding from Israel Innovation Authority and Mayo Shattuck.
Which investors participated in Olive Diagnostics' funding round in January 2023?
In January 2023, Olive Diagnostics received funding from Ventruing and Keren Maccabi.
Who led Olive Diagnostics' funding round in March 2023?
Mekorot led Olive Diagnostics' funding round in March 2023.
Which investors participated in Olive Diagnostics' most recent funding round in May 2023?
In May 2023, Olive Diagnostics received $2,750,000 USD in a funding round led by.
What is the current employee count for Olive Diagnostics?
Olive Diagnostics has 11-50 employees.
Who is the Founder and CEO of Olive Diagnostics?
Guy Goldman is the Founder and CEO of Olive Diagnostics.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Data StorageCloudArtificial IntelligenceSensingOptic
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratoriesPatientsConsumersDemographics & FamilySeniors
Business model
B2B2CB2C

Highlights

1 PatentsVerified

Tags

medical-device-manufacturersdiagnosticsartificial-intelligencecloudhealthcare-providerssensorsearly-detectiondigital-healthcarehospitalsclinicsdata-analyticsmedical-devicespatientsdisease-managementseniorsreal-timeurinary-systembiomarkersremote-monitoring
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)